Threat to pharmaceutical marks as controversial provision is resurrected
French legislators have resurrected a provision that would effectively prohibit drugs manufacturers from enforcing their trademark rights in a tablet once the relevant patent has expired.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.